Page 17 - RCOE 23-3

infection in respiratory diseases-a review. J Med Life. 2013 Spc 15; 6(3): 244–248.
19. Silvana P. Barros, Robert Suruki,2 Zvi G. Loewy, James D. Beck, and Steven Offenbacher, A. Cohort Study of the Impact of Tooth Loss and Periodontal Disease on Respiratory Events among COPD Subjects: Modulatory Role of Systemic Biomarkers of Inflammation. PLoS One. 2013; 8(8): e68592.
20. Glass RT, Conrad RS, Bullard JW, Goodson LB, Mehta N, et al. Evaluation of microbial flora found in previously worn prostheses from the Northeast and Southwest regions of the United States. J Prosthet Dent. 2010; 103: 384–389
21. Peter KP, Mute BR, Doiphode SS, Bardapurkar SJ, Borkar MS, Raje DV. Association between Periodontal Disease and Chronic Obstructive Pulmonary Disease - A Reality or Just a Dogma. J Periodontol. 2013 Jan 23. 22. Ledić K, Marinković S, Puhar I, Spalj S, Popović-Grle S, Ivić-Kardum M, Samarzija M, Plancak D.Periodontal disease increases risk for chronic obstructive pulmonary disease. Coll Antropol. 2013 Spc; 37(3):937-42. 23. Chrysanthakopoulos NA, Chrysanthakopoulos PA. Association bet- ween indices of clinically-defined periodontitis and self-rpcorted history of systemic medical conditions. J Investig Clin Dent. 2016 Feb; 7(1):27-36. 24. Öztekin G1, Baser U, Kucukcoskun M, Tanrikulu-Kucuk S, Ademoglu E, Isik G, Ozkan G, Yalcin F, Kiyan E.The association between perio- dontal disease and chronic obstructive pulmonary disease: a case control study. COPD. 2014 Aug; 11(4):424-30.
25. Neeta Vijay Bhavsar, Bela Dilip Dave,1 Nilam Ashokkumar Brahmbhatt, and Rishikesh Parekh. Periodontal status and oral health behavior in hospitalized patients with chronic obstructive pulmonary disease. J Nat Sci Biol Med. 2015 Aug; 6 (Suppl 1): S93–S97.
26. Brooke E. Agado; Brian Crawford; Jacob DeLaRosa; Denise M. Bowen; Teri Peterson; Karen Neill, SANE–A; Carlene Paarmann. Journal of Dental Hygiene. 2012. 86, 3:204-214.
27. Devlin J. Patients with chronic obstructive pulmonary disease: manage- ment considerations for the dental team. Br Dent J. 2014; 217 (5): 235-7 28. Zhou X, Han J, Song Y, Zhang J, Wang Z. Serum levels of 25-hydro- xyvitamin D, oral health, and chronic obstructive pulmonary disease. J Clin Periodontol 2012; 39: 350–356.
29. Janoff A, Sloan B, Weinbaum G, Damiano V, Sandhaus RA, Elias J, Kimbel P. Experimental emphysema induced with purified human neu- trophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis. 1977; 115:461–478.
30. Fujita J, Nelson NL, Daughton DM, Dobry CA, Spurzem JR, Irino S, Rennard SI. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am Rev Respir Dis.1990; 142:57–62.
31. Donnelly LE, Barnes PJ. Defective phagocytosis in airways disease. Chest.2012; 141:1055–1062.
32. Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008; 3:253–268.
33. Wood AM, Stockley RA. The genetics of chronic obstructive pulmo- nary disease. Respir Res. 2006; 7:130.
34. Wallin-Bengtsson V, Piitulainen E, Hamberg K, Lindh C, Bratthall G. Alpha-1-antitrypsin deficiency and periodontitis, a pilot study. Swed Dent J.2011; 35:33–40.
35. Sorsa T, Tjaderhane L, Konttinen YT, et al. Matrix metalloproteina- ses: contribution to pathogenesis and treatment of periodontal inflam- mation. Ann Med 2006; 38:306–321.
36. Kuula H, Salo T, Pirila¨ E, et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingi- valis induced periodontitis. Infect Immun 2009;77:850–859.
37. Demkow U, van Overveld FJ. Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment. Eur J Med Res 2010; 15 (suppl 2):27–35.
38. Vernooy JH, Lindeman JH, Jacobs JA, et al. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced spu- tum from patients with COPD. Chest 2004; 126:1082–1010.
39. Usher AK, Stockley RA. The link between chronic periodontitis and COPD: a common role for the neutrophil?. BMC Med. 2013 Nov 13; 11:241 40. Scott DA, Krauss J. Neutrophils in periodontal inflammation. Front Oral Biol. 2012; 15:56–83.
41. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012 30:459–489.
42. Sapey E, Stockley JA, Greenwood H, Ahmad A, Bayley D, Lord JM, Insall RH, Stockley RA. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011; 183:1176–1186. 43. Nussbaum G, Shapira L. How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol. 2011; 38:49–59. 44. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obs- tructive pulmonary disease. Respir Med 2009; 103:1231–1238.
45. de Torres JP, Casanova C, Pinto-Plata V, et al. Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study. PLoS ONE 2011; 6(1):e16021.
46. YıldırımE, Kormi I, Bas¸og˘lu O¨ K, Gu¨rgu¨n A, Kaval B, Sorsa T, Buduneli N. Periodontal health and serum, saliva matrix metallopro- teinases in patients with mild chronic obstructive pulmonary disease. J Periodont Res 2012;
47. Turino GM. Proteases in COPD: a critical pathway to injury. Chest 2007; 132:1724–1725.
48. Loukides S, Bakakos P, Kostikas K. Oxidative stress in patients with COPD. Curr Drug Targets. 2011; 12:469–477.
49. Neofytou E, Tzortzaki EG, Chatziantoniou A, Siafakas NM. DNA damage due to oxidative stress in chronic obstructive pulmonary disease (COPD) Int J Mol Sci. 2012; 13: 16853–16864.
50. Chapple IL, Matthews JB. The role of reactive oxygen and anti- oxidant species in periodontal tissue destruction. Periodontol 2000. 2007;43:160–232.
51. Tzortzaki EG, Dimakou K, Neofytou E, Tsikritsaki K, Samara K, Avgousti M, Amargianitakis, Gousiou A, Menikou S, Siafakas NM. Oxidative DNA damage and somatic mutations: a link to the molecu- lar pathogenesis of chronic inflammatory airway diseases. Chest. 2012; 141:1243–1250.
52. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med.2008; 178:906–912.
91 ➤➤
La PC en el paciente con patología respiratoria. PC y EPOC. López-Arranz Monge, G.